tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EOLS Stock Latest News

Strategic Leadership and Stability Drive Buy Rating for Evolus
RatingsStrategic Leadership and Stability Drive Buy Rating for Evolus
30d ago
EOLS
Evolus Appoints Tatjana Mitchell as New CFO
PremiumCompany Announcements
Evolus Appoints Tatjana Mitchell as New CFO
1M ago
8K
EOLS
Evolus appoints Tatjana Mitchell as CFO
PremiumThe Fly
Evolus appoints Tatjana Mitchell as CFO
1M ago
EOLS
Evolus announces Evolysse Sculpt trial meets primary endpoint
PremiumThe Fly
Evolus announces Evolysse Sculpt trial meets primary endpoint
1M ago
EOLS
Evolus submits Evolysse premarket approval application to FDA
PremiumThe Fly
Evolus submits Evolysse premarket approval application to FDA
2M ago
EOLS
Evolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
PremiumCompany AnnouncementsEvolus, Inc. Advances Safety Study of NUCEIVA for Glabellar Lines
2M ago
EOLS
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
Premium
Company Announcements
Evolus, Inc. Faces Financial Instability Amid Economic Uncertainty and Consumer Spending Risks
2M ago
EOLS
Evolus, Inc. Earnings Call: Mixed Sentiments and Strategic Goals
Premium
Company Announcements
Evolus, Inc. Earnings Call: Mixed Sentiments and Strategic Goals
2M ago
EOLS
Evolus: Strategic Growth and Cost Optimization Support Buy Rating Amid Market Challenges
PremiumRatings
Evolus: Strategic Growth and Cost Optimization Support Buy Rating Amid Market Challenges
2M ago
EOLS
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
PremiumThe Fly
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
2M ago
U
GO
Evolus price target lowered to $18 from $21 at BTIG
PremiumThe Fly
Evolus price target lowered to $18 from $21 at BTIG
2M ago
EOLS
Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
PremiumThe Fly
Evolus cut to Hold at Needham after ‘significant’ Jeuveau downturn
2M ago
EOLS
Evolus downgraded to Hold from Buy at Needham
PremiumThe FlyEvolus downgraded to Hold from Buy at Needham
2M ago
EOLS
Evolus price target lowered to $20 from $27 at H.C. Wainwright
Premium
The Fly
Evolus price target lowered to $20 from $27 at H.C. Wainwright
2M ago
EOLS
Evolus, Inc. Reports Q2 2025 Financial Results
Premium
Company Announcements
Evolus, Inc. Reports Q2 2025 Financial Results
2M ago
EOLS
Evolus Appoints New Principal Financial Officer
PremiumCompany Announcements
Evolus Appoints New Principal Financial Officer
2M ago
8K
EOLS
Evolus reports Q2 EPS (27c), consensus (9c)
PremiumThe Fly
Evolus reports Q2 EPS (27c), consensus (9c)
2M ago
EOLS
Evolus sees FY25 revenue $295M-$305M, consensus $348.2M
PremiumThe Fly
Evolus sees FY25 revenue $295M-$305M, consensus $348.2M
2M ago
EOLS
Evolus down 25% at $6.66 after Q2 earnings miss
PremiumThe Fly
Evolus down 25% at $6.66 after Q2 earnings miss
2M ago
EOLS
Evolus, Inc. Advances NUCEIVA Safety Study: Key Insights for Investors
PremiumCompany AnnouncementsEvolus, Inc. Advances NUCEIVA Safety Study: Key Insights for Investors
2M ago
EOLS
Evolus launches Nuceiva neurotoxin in France through Symatese partnership
Premium
The Fly
Evolus launches Nuceiva neurotoxin in France through Symatese partnership
3M ago
EOLS
Evolus: Strategic Positioning and Growth Potential Drive Buy Rating
Premium
Ratings
Evolus: Strategic Positioning and Growth Potential Drive Buy Rating
4M ago
EOLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >